UM
TMO icon

Ulysses Management’s Thermo Fisher Scientific TMO Stock Holding History

Ulysses Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,000
Closed -$1.47M – 50
2026
Q1 		$1.47M Hold
3,000
– – 0.18% 28
2025
Q4 		$1.74M Buy
+3,000
New +$1.7M 0.32% 30

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ulysses Management's TMO Position: Q2 2026 in Review

Ulysses Management sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 3,000 shares — an estimated $1.47M sold.

Ulysses Management first reported a position in TMO in Q4 2025 and held it in 2 quarters. The position peaked at $1.74M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Ulysses Management reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Ulysses Management sold 3,000 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.47M.
  • Ulysses Management first reported a position in Thermo Fisher Scientific in Q4 2025 and held it in 2 quarters.
  • Ulysses Management's Thermo Fisher Scientific position peaked at $1.74M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ulysses Management's 13F filing for Q2 2026, filed 14 Aug 2026.